Tiegs R D, Lohse C M, Wollan P C, Melton L J
Division of Endocrinology, Metabolism and Nutrition, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA.
Bone. 2000 Sep;27(3):423-7. doi: 10.1016/s8756-3282(00)00333-1.
Existing data on the epidemiology of Paget's disease of bone are limited by the lack of directly determined secular trends in clinically diagnosed Paget's disease. In the current study, we examine trends in Paget's disease incidence in Olmsted County, MN, using data from the Rochester Epidemiology Project medical records linkage system. During the period 1950 through 1994, 236 Olmsted County, MN residents were diagnosed for the first time with Paget's disease of bone at a mean age of 69.6 years. Overall, there were 129 (54.7%) men and 107 women, and the age-adjusted incidence of Paget's disease was 12.7 per 100,000 person-years (95% CI 10.4-14.9) among the men compared with 7.0 per 100,000 person-years (95% CI 5.6-8.3) among Olmsted County women (male/female ratio of 1.8:1). The higher incidence in males compared with females and the increase in incidence with older age were statistically significant. The incidence of Paget's disease in Olmsted County seems to have increased over the first part of the study period and then declined. This may have resulted from ascertainment bias: the introduction of a 12-test automated serum chemistry panel in 1974 might have led to a sudden increase in the apparent incidence of Paget's disease followed by a compensatory decrease. In addition, there was a decrease in the proportion of patients who were symptomatic at diagnosis, from 36% in 1950-1959 to 27% in 1980-1994. This finding also suggests that routine measurement of alkaline phosphatase may have led to more diagnosis of asymptomatic individuals. The subsequent fall in the incidence of Paget's disease is consistent with previous reports, although this apparent decline could be artifactual to the extent that the reservoir of undiagnosed cases in the population was exhausted by earlier testing.
关于骨佩吉特病的流行病学现有数据,因缺乏临床诊断的佩吉特病直接确定的长期趋势而受到限制。在本研究中,我们利用罗切斯特流行病学项目医疗记录链接系统的数据,研究了明尼苏达州奥尔姆斯特德县佩吉特病的发病率趋势。在1950年至1994年期间,236名明尼苏达州奥尔姆斯特德县居民首次被诊断患有骨佩吉特病,平均年龄为69.6岁。总体而言,有129名(54.7%)男性和107名女性,男性中佩吉特病的年龄调整发病率为每10万人年12.7例(95%置信区间10.4 - 14.9),而奥尔姆斯特德县女性为每10万人年7.0例(95%置信区间5.6 - 8.3)(男/女比例为1.8:1)。男性发病率高于女性以及发病率随年龄增长而增加具有统计学意义。在研究的第一阶段,奥尔姆斯特德县佩吉特病的发病率似乎有所上升,然后下降。这可能是由于确诊偏倚:1974年引入的12项自动血清化学检测组合可能导致佩吉特病的表观发病率突然上升,随后出现补偿性下降。此外,诊断时有症状的患者比例有所下降,从1950 - 1959年的36%降至1980 - 1994年的27%。这一发现还表明,碱性磷酸酶的常规检测可能导致更多无症状个体被诊断出来。佩吉特病发病率随后的下降与先前的报告一致,尽管这种明显的下降可能是人为造成的,因为人群中未确诊病例库因早期检测而耗尽。